Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5d11ede84a55c6cd4eaa8c94c0e319d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
filingDate |
2006-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757d7baec6a9c2c01daf5ac29f74a2db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16509b89573686b23bdb2c458fe0acb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128cc01082563cfb55c4c1d94a119c88 |
publicationDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006292683-A1 |
titleOfInvention |
Cross-beta structures on microbial organisms |
abstract |
The present invention discloses the use of a protease inhibitor in the preparation of a medicament for the treatment of microbial infections. The invention further discloses the use of a compound binding to a cross-β structure or an antibody specific for a cross-β structure in the preparation of a medicament for the treatment of microbial infections. The invention further discloses methods for attenuating microbial pathogens by deleting at least part of a gene encoding a cross-β structure forming protein. The invention also discloses an antimicrobial composition, and a kit for detecting microbial contamination in a solution or a substance. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008267948-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009202980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006045853-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008249606-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015126-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114832-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067187-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008207488-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008376-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008118529-A1 |
priorityDate |
2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |